News About: Pharm. Industry
Positive list system to cause industries and patients heavy burdens.
The positive list system raises a controversial backlash in the pharmaceutical industry. After the government's advanced announcement of its legislation plan, the drug industry made a loud voice with slight different ...
AZ Korea to raise legal action on NHI price down.
AZ Korea raised a legal process against the NHI price down of Iressa, an anti lung cancer drug, for the injunction of the price down measures.
The MOHW earlier reduced 11% of NHI price for Iressa taking effect from...
Bukwang's clevudine to grab bigger market share
Bukwang Pharm is expected to expand its market share of the domestic anti-hepatitis B drug market dominated by GlaxoSmithKline (GSK), analysts said.
Clevudine, the first-domestically-made medication for hepatitis B...
Major pharmaceutical firm report strong profit in first half
Korea's major drug makers reported a strong net profit in the first half of this year, driven by robust sales of drugs and thrift management.
Dong-A Pharm earned 16.1 billion won in net profit for the first h...
New anti-hepatitis B drug to make debut in December
The Korea Food and Drug Administration (KFDA) approved a local pharmaceutical company's anti-hepatitis B drug on July 28 and the market for anti-hepatits B medicines dominated by imported drugs is expected to enter fi...
Hepatitis B market to be contested by 3 pharmaceutical firms
Pharmaceutical business sources that domestic hepatitis B market will emerge as an arena of tripartite competition GlaxoSmithKline's Zeffix (lamivudine) and Hepsera (adefovir), Bukwang Pharm's Levovir (clevudine) and...
Celltrion signs manufacturing agreement with Bristol-Myers Squibb Company
Celltrion announced on July 31 that it has completed an agreement with Bristol-Myers Squibb Company to manufacture biologic products being developed by Bristol-Myers Squibb.
In the bio-complex, Celltrion will initi...
Notice to our readers
Due to summer vacation English Yakup Daily will not publish August 3(Thursday), thru August 7(Monday), 2006.
We resume publication on August 8(Tuesday), 2006.
Lee Won-sik named Pfizer Korea Medical DirectorPfizer Korea said it has appointed Lee Won-sik as its new medical director.
Lee, 44, will head the company's research and development business unit.
A graduate of SNU's me...
|
Pharmaceutical firms seeking to hire more employees in sales and R&D sector
A number of pharmaceutical firms are struggling to increase the proportion of sales and R&D workforce for their sustained growth, according to data released by the Korea Pharmaceutical Manufacturers Association (KPMA)...
